Nutritional Intervention and Respiratory Infections in Older Subjects
NCT ID: NCT01971112
Last Updated: 2013-10-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
320 participants
INTERVENTIONAL
2013-10-31
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A previous systematic review and meta-analysis of randomised controlled trials (RCT), which included papers published before January 2004, found no evidence of an effect of MVM supplementation on infection rate \[6\] or duration \[7\] in older people. However, considerable clinical and methodological heterogeneity was present in the studies included in this earlier review. The investigators have updated this earlier systematically review of the evidence that MVM supplementation is effective in reducing the incidence of infection in older people. Sub-group analysis explored the effect site of residence (nursing homes or dwellings) of study participants, primary outcome measure (self report or clinical evaluation), and baseline micronutrients status of enrolled subjects \[8\].
The investigators found no evidence of benefits from multivitamin and minerals supplementation on the rate of infection or the odds ratio of infection in aging subjects. The investigators also found no benefit of intervention in the subgroups analysed. Sensitivity analysis of those studies evaluated as free of bias did not substantially alter this conclusion.
The included trials were heterogeneous in sample size (range 33 to 2799), duration (range 4 to 24 months), and outcome measures. The lack of benefit of the intervention in studies which found variable percent of subjects with some micronutrient deficiencies at enrolment could be related to some characteristics of the included trials: All studies but that of Avenell \[9\] had not determined the micronutrients status of the target population before the enrolment. Therefore, the formulas of multivitamin and mineral supplements used were not aimed to correct any pre-specified deficiency. Moreover, those studies had different considerations to define the formula, which explains the large variability of the supplements across the studies. Finally, the assessment of the micronutrient status was also variable across the studies: dietary intake evaluation and/or micronutrients blood concentration, which affects the consistency of this subgroup meta-analysis.
It is noteworthy that all studies except one \[10\] have been carried out in developed countries where the nutritional status of aging populations seems to be better than that reported by studies carried out in developing countries. In fact, although the variability of the assessment methods do not allow to draw a clear conclusion on the baseline nutritional status of the subjects included in the analysed studies, the prevalence of deficiencies and the number of micronutrients found deficient are evidently lower than those referred in studies from developing countries such as those carried out in Ecuador \[11\]. The remaining study was carried out in a middle-income country and although data on baseline nutritional status of enrolled subjects was not published, presumably their micronutrient status is somehow similar to that found in developed countries.
Based on these considerations, it would be novel to find evidence to support the hypothesis on the benefit of improving vitamin and mineral consumption, to enhance immune function and decrease infectious disease episodes in elderly suffering from extent and multiple micronutrient deficiencies as those of developing countries.
Our research group has been the first to study the nutritional, immunological, and health status of Ecuadorian older people, who live in poor peri-urban neighbourhoods of Quito, a city on the Andean Region. The investigators carried out a preliminary study of 145 older people (age ≥65 years), which revealed inadequate intake of protein and multiple micronutrients as well as high prevalence of recalled infectious diseases assessed by physician or hospital visits \[12 \]. To better define these findings, the investigators performed a larger and adequately powered cross-sectional study in Quito with 352 older people (225 women), whose results have been published in two articles.\[1, 11 \] Substantial deficiencies (\> 30% of subjects) of serum/blood concentrations were found for vitamins C (47%), folate (32%), and zinc (43%) \[1\]. More than 20% of subjects were also vitamins B6, and B12 deficient \[1\]. Severe vitamin D deficiency was found in \<15% of subjects and moderate deficiency was found in 65% of males, and 87% of females \[11\]. Moreover, 30% of men and 40% of women were anaemic based on altitude-adjusted haemoglobin values \[1, 13\]. When dietary intake was assessed the percent of deficient subjects was even higher \[11\].
There was correlation between dietary intake and blood concentration of some of these micronutrients \[11\]. Therefore, most of these older Ecuadorians suffer from multiple micronutrient deficiencies due mainly to dietary restriction. This situation makes them amenable to MVM interventions aimed to correct their nutritional status.
Blood deficiency of any one or more of the following micronutrients vitamin C, vitamin E, pyridoxal5-phosphate (PLP), folate, iron, or zinc was strongly associated with history of RI (OR 4.0; 1.76, 9.06) \[1 \].
Delayed-type hypersensitivity (DTH) was considerably lower than that observed in US elderly especially to Trichophyton and tetanus toxoid \[1 \] DTH is an in vivo indicator of cellular immune response status. Vitamin C and zinc concentrations were significantly associated with Interferon gamma (IFN-γ) concentrations \[1\]. Serum iron and zinc were significantly associated with Interleukin 2 (IL-2) levels \[1\]. Since IFN-γ and IL-2 are T-dependent cytokines these correlations suggest that deficiency of those micronutrients may explain the impaired cellular immune response as assessed by DTH. High plasma CRP (\>3 mg/l) was present in 49% of the participants, which could be a proxy of increased pro-inflammatory cytokines \[11\]. There was no correlation between protein, carbohydrate, or lipid intake and immune response or infection.
Taken together, data from these previous studies in Ecuador suggest that both risk for infections and impaired immune function is associated with deficiencies of critical vitamins and minerals in Ecuadorian older people. Although it is important to be cautious to conclude on these studies due to their cross-sectional design, it seems to be necessary to evaluate a nutritional intervention intended to provide those micronutrients found to be deficient to improve the immune and health status of elderly Ecuadorians. This approach is different from that of the previous trials carried out in developed countries which had not evaluated the micronutrient status of the target population before the enrolment and, in consequence, had not defined a MVM formula aimed to correct specific deficiencies. Moreover, the micronutrients deficiencies found in Ecuadorian older subjects appear to affect largely higher percent of subjects and include more micronutrients than those found at enrolment in subjects included in studies carried out in developed countries. Therefore,the hypothesis is that provision of MVM supplements to poor Ecuadorian subjects aimed to correct their specific micronutrients deficiencies may prove beneficial to reduce the incidence of respiratory infections via improvement of their immune response assessed by DTH test, and decreased CRP concentration as proxy of the down regulation of pro-inflammatory cytokines. Since cathelicidin, an antimicrobial peptide produced by neutrophils, seems to be increased by vitamin D status \[14\], the measure of this peptide in supernatants of cultured cells from the upper respiratory mucosa will be included. Thus, DTH and cathelicidin would provide an assessment of both innate and adaptive immunity. This study will be the first to be undertaken in an aging population of a developing country.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Multivitamins and minerals
Experimental: X: Multivitamins and minerals (MVM) Arm X: 1X US-RDA of vitamins A, D,E,B6,B12, folate, copper and iron plus 500 mg vitamin C, and 14 mg of Zinc
Multivitamins and minerals
Dietary supplement Arm X: Vitamins B6, B12,folic acid, A, D, E, and Iron, and copper at one US-RDA. Plus vitamin C 500 mg, and zinc 14 mg will be given orally daily during 52 weeks.
Placebo
Multivitamins and minerals
Dietary supplement Arm X: Vitamins B6, B12,folic acid, A, D, E, and Iron, and copper at one US-RDA. Plus vitamin C 500 mg, and zinc 14 mg will be given orally daily during 52 weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Multivitamins and minerals
Dietary supplement Arm X: Vitamins B6, B12,folic acid, A, D, E, and Iron, and copper at one US-RDA. Plus vitamin C 500 mg, and zinc 14 mg will be given orally daily during 52 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Mental competence
* Written informed consent
Exclusion Criteria
* Tuberculosis
* Immunosuppressive therapeutics.
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad Central del Ecuador
OTHER
Corporacion Ecuatoriana de Biotecnologia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Fernando Sempertegui MD
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Atucucho neighborhood
Quito, Pichincha, Ecuador
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Fernando E Sempertegui, MD
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Sempertegui F, Estrella B, Tucker KL, Hamer DH, Narvaez X, Sempertegui M, Griffiths JK, Noel SE, Dallal GE, Selhub J, Meydani SN. Metabolic syndrome in the elderly living in marginal peri-urban communities in Quito, Ecuador. Public Health Nutr. 2011 May;14(5):758-67. doi: 10.1017/S1368980010002636. Epub 2010 Oct 19.
Hamer DH, Sempertegui F, Estrella B, Tucker KL, Rodriguez A, Egas J, Dallal GE, Selhub J, Griffiths JK, Meydani SN. Micronutrient deficiencies are associated with impaired immune response and higher burden of respiratory infections in elderly Ecuadorians. J Nutr. 2009 Jan;139(1):113-9. doi: 10.3945/jn.108.095091. Epub 2008 Dec 3.
Sempertegui F, Estrella B, Elmieh N, Jordan M, Ahmed T, Rodriguez A, Tucker KL, Hamer DH, Reeves PG, Meydani SN. Nutritional, immunological and health status of the elderly population living in poor neighbourhoods of Quito, Ecuador. Br J Nutr. 2006 Nov;96(5):845-53. doi: 10.1017/bjn20061802.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
378 DGIP-I
Identifier Type: -
Identifier Source: org_study_id